Advair
Product Images NDC 21695-361

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Advair (NDC 21695-361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Cumulative Incidence Of Asthma-related Deaths In The 28-week Salmeterol Multi-center Asthma Research Trial (smart), By Duration Of Treatment (0bfe9d76 1b0e 47a4 831d 097168d66577 01)

Figure 1. Cumulative Incidence Of Asthma-related Deaths In The 28-week Salmeterol Multi-center Asthma Research Trial (smart), By Duration Of Treatment (0bfe9d76 1b0e 47a4 831d 097168d66577 01)
Not available.*
FDA Label Image

Fluticasone Propionate Chemical Structure (0bfe9d76 1b0e 47a4 831d 097168d66577 02)

Fluticasone Propionate Chemical Structure (0bfe9d76 1b0e 47a4 831d 097168d66577 02)
FDA Label Image

Salmeterol Xinafoate Chemical Structure (0bfe9d76 1b0e 47a4 831d 097168d66577 03)

Salmeterol Xinafoate Chemical Structure (0bfe9d76 1b0e 47a4 831d 097168d66577 03)
FDA Label Image

Figure 2. Mean Percent Change From Baseline In Fev1 In Patients With Asthma Previously Treated With Either Inhaled Corticosteroids Or Salmeterol (study 1) (0bfe9d76 1b0e 47a4 831d 097168d66577 04)

Figure 2. Mean Percent Change From Baseline In Fev1 In Patients With Asthma Previously Treated With Either Inhaled Corticosteroids Or Salmeterol (study 1) (0bfe9d76 1b0e 47a4 831d 097168d66577 04)
FDA Label Image

Figure 3. Percent Change In Serial 12-hour Fev1 In Patients With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (study 1) (0bfe9d76 1b0e 47a4 831d 097168d66577 05)

Figure 3. Percent Change In Serial 12-hour Fev1 In Patients With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (study 1) (0bfe9d76 1b0e 47a4 831d 097168d66577 05)
FDA Label Image

Figure 4. Percent Change In Serial 12-hour Fev1 In Patients With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (study 1) (0bfe9d76 1b0e 47a4 831d 097168d66577 06)

Figure 4. Percent Change In Serial 12-hour Fev1 In Patients With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (study 1) (0bfe9d76 1b0e 47a4 831d 097168d66577 06)
FDA Label Image

Figure 5. Predose Fev1: Mean Percent Change From Baseline In Patients With Chronic Obstructive Pulmonary Disease (0bfe9d76 1b0e 47a4 831d 097168d66577 07)

Figure 5. Predose Fev1: Mean Percent Change From Baseline In Patients With Chronic Obstructive Pulmonary Disease (0bfe9d76 1b0e 47a4 831d 097168d66577 07)
Not available. The text contains several errors making it incomprehensible.*
FDA Label Image

Figure 6. Two-hour Postdose Fev1: Mean Percent Changes From Baseline Over Time In Patients With Chronic Obstructive Pulmonary Disease (0bfe9d76 1b0e 47a4 831d 097168d66577 08)

Figure 6. Two-hour Postdose Fev1: Mean Percent Changes From Baseline Over Time In Patients With Chronic Obstructive Pulmonary Disease (0bfe9d76 1b0e 47a4 831d 097168d66577 08)
This appears to be a table of data related to a medical study involving the use of Advair Diskus, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The table lists the baseline forced expiratory volume (FEV) for each participant and their corresponding FEV after taking Advair Diskus or a placebo medication. The results suggest that Advair Diskus may lead to an improvement in FEV compared to the placebo, as the FEV values for those taking Advair Diskus are higher than those taking the placebo.*
FDA Label Image

Diskus Parts (0bfe9d76 1b0e 47a4 831d 097168d66577 09)

Diskus Parts (0bfe9d76 1b0e 47a4 831d 097168d66577 09)
The text appears to be describing the components of a medical device. The device seems to have a lever and a mouthpiece, with a dose indicator and an outer case. There is also a reference to a "Thumbarip" but it's unclear what this refers to. It is likely that this device is used for administering medication.*
FDA Label Image

Figure 1 (0bfe9d76 1b0e 47a4 831d 097168d66577 10)

Figure 1 (0bfe9d76 1b0e 47a4 831d 097168d66577 10)
FDA Label Image

Figure 2 (0bfe9d76 1b0e 47a4 831d 097168d66577 11)

Figure 2 (0bfe9d76 1b0e 47a4 831d 097168d66577 11)
FDA Label Image

Figure 3 (0bfe9d76 1b0e 47a4 831d 097168d66577 12)

Figure 3 (0bfe9d76 1b0e 47a4 831d 097168d66577 12)
FDA Label Image

Figure 4 (0bfe9d76 1b0e 47a4 831d 097168d66577 13)

Figure 4 (0bfe9d76 1b0e 47a4 831d 097168d66577 13)
FDA Label Image

Figure 5 (0bfe9d76 1b0e 47a4 831d 097168d66577 14)

Figure 5 (0bfe9d76 1b0e 47a4 831d 097168d66577 14)
FDA Label Image

Figure 6 (0bfe9d76 1b0e 47a4 831d 097168d66577 15)

Figure 6 (0bfe9d76 1b0e 47a4 831d 097168d66577 15)
FDA Label Image

Advair Diskus 100/500mcg (0bfe9d76 1b0e 47a4 831d 097168d66577 16)

Advair Diskus 100/500mcg (0bfe9d76 1b0e 47a4 831d 097168d66577 16)
This appears to be a combination of random unintelligible text and snippets of product information. It is not possible to generate a useful description from it.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.